PortfoliosLab logo
BIS vs. BIB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIS and BIB is -0.62. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0
Correlation: -0.6

Performance

BIS vs. BIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Nasdaq Biotechnology (BIS) and ProShares Ultra Nasdaq Biotechnology (BIB). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%NovemberDecember2025FebruaryMarchApril
-99.57%
506.15%
BIS
BIB

Key characteristics

Sharpe Ratio

BIS:

-0.01

BIB:

-0.24

Sortino Ratio

BIS:

0.29

BIB:

-0.06

Omega Ratio

BIS:

1.03

BIB:

0.99

Calmar Ratio

BIS:

-0.01

BIB:

-0.15

Martin Ratio

BIS:

-0.03

BIB:

-0.60

Ulcer Index

BIS:

19.51%

BIB:

16.54%

Daily Std Dev

BIS:

42.05%

BIB:

41.50%

Max Drawdown

BIS:

-99.77%

BIB:

-67.24%

Current Drawdown

BIS:

-99.69%

BIB:

-59.23%

Returns By Period

In the year-to-date period, BIS achieves a 5.59% return, which is significantly higher than BIB's -11.72% return. Over the past 10 years, BIS has underperformed BIB with an annualized return of -17.12%, while BIB has yielded a comparatively higher -5.44% annualized return.


BIS

YTD

5.59%

1M

8.23%

6M

25.01%

1Y

-2.08%

5Y*

-12.14%

10Y*

-17.12%

BIB

YTD

-11.72%

1M

-12.51%

6M

-27.13%

1Y

-8.63%

5Y*

-6.61%

10Y*

-5.44%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIS vs. BIB - Expense Ratio Comparison

Both BIS and BIB have an expense ratio of 0.95%.


Expense ratio chart for BIS: current value is 0.95%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
BIS: 0.95%
Expense ratio chart for BIB: current value is 0.95%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
BIB: 0.95%

Risk-Adjusted Performance

BIS vs. BIB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIS
The Risk-Adjusted Performance Rank of BIS is 2424
Overall Rank
The Sharpe Ratio Rank of BIS is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of BIS is 3030
Sortino Ratio Rank
The Omega Ratio Rank of BIS is 2727
Omega Ratio Rank
The Calmar Ratio Rank of BIS is 2121
Calmar Ratio Rank
The Martin Ratio Rank of BIS is 2121
Martin Ratio Rank

BIB
The Risk-Adjusted Performance Rank of BIB is 1313
Overall Rank
The Sharpe Ratio Rank of BIB is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of BIB is 1414
Sortino Ratio Rank
The Omega Ratio Rank of BIB is 1414
Omega Ratio Rank
The Calmar Ratio Rank of BIB is 1212
Calmar Ratio Rank
The Martin Ratio Rank of BIB is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIS vs. BIB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BIS, currently valued at -0.01, compared to the broader market-1.000.001.002.003.004.00
BIS: -0.01
BIB: -0.24
The chart of Sortino ratio for BIS, currently valued at 0.29, compared to the broader market-2.000.002.004.006.008.00
BIS: 0.29
BIB: -0.06
The chart of Omega ratio for BIS, currently valued at 1.03, compared to the broader market0.501.001.502.002.50
BIS: 1.03
BIB: 0.99
The chart of Calmar ratio for BIS, currently valued at -0.01, compared to the broader market0.002.004.006.008.0010.0012.00
BIS: -0.01
BIB: -0.15
The chart of Martin ratio for BIS, currently valued at -0.03, compared to the broader market0.0020.0040.0060.00
BIS: -0.03
BIB: -0.60

The current BIS Sharpe Ratio is -0.01, which is higher than the BIB Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of BIS and BIB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.01
-0.24
BIS
BIB

Dividends

BIS vs. BIB - Dividend Comparison

BIS's dividend yield for the trailing twelve months is around 3.42%, more than BIB's 2.12% yield.


TTM2024202320222021202020192018
BIS
ProShares UltraShort Nasdaq Biotechnology
3.42%3.73%1.75%0.00%0.00%0.45%2.11%0.37%
BIB
ProShares Ultra Nasdaq Biotechnology
2.12%1.69%0.07%0.03%0.00%0.00%0.00%0.00%

Drawdowns

BIS vs. BIB - Drawdown Comparison

The maximum BIS drawdown since its inception was -99.77%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for BIS and BIB. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%NovemberDecember2025FebruaryMarchApril
-99.69%
-59.23%
BIS
BIB

Volatility

BIS vs. BIB - Volatility Comparison

ProShares UltraShort Nasdaq Biotechnology (BIS) and ProShares Ultra Nasdaq Biotechnology (BIB) have volatilities of 24.60% and 24.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
24.60%
24.42%
BIS
BIB